| scholarly article | Q13442814 |
| P2093 | author name string | Ellen Evans | |
| Nathaniel Collins | |||
| James S MacDonald | |||
| Christopher Horvath | |||
| Richard E Morrissey | |||
| James Patrick | |||
| Eileen A Snyder | |||
| P2860 | cites work | WAF1, a potential mediator of p53 tumor suppression | Q27861121 |
| p53 mutations in human cancers | Q28302973 | ||
| Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours | Q29547697 | ||
| Cancer. p53, guardian of the genome | Q29615610 | ||
| Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6 | Q29622924 | ||
| Abrogation of oncogene-associated apoptosis allows transformation of p53-deficient cells | Q35088549 | ||
| p53 function and dysfunction | Q35721291 | ||
| Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus | Q35861543 | ||
| Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. | Q37013182 | ||
| Wild-type p53 is a cell cycle checkpoint determinant following irradiation | Q37152060 | ||
| How loops, beta sheets, and alpha helices help us to understand p53. | Q40694267 | ||
| Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer | Q41445691 | ||
| Genetic mechanisms of tumor suppression by the human p53 gene | Q41710706 | ||
| Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models | Q45886517 | ||
| Inoculation of Pigs with Adenoviruses of Man | Q59093780 | ||
| Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene | Q64379227 | ||
| Tumor suppressor genes | Q72455787 | ||
| Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype | Q72785614 | ||
| P433 | issue | 2 | |
| P921 | main subject | Adenoviridae | Q193447 |
| P304 | page(s) | 256-265 | |
| P577 | publication date | 2002-02-01 | |
| P1433 | published in | Toxicological Sciences | Q2446966 |
| P1476 | title | Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene | |
| P478 | volume | 65 |
| Q40424880 | Adenoviral p53 gene transfer and gemcitabine in three patients with liver metastases due to advanced pancreatic carcinoma |
| Q33713324 | Cancer-induced expansion and activation of CD11b+ Gr-1+ cells predispose mice to adenoviral-triggered anaphylactoid-type reactions |
| Q64378490 | Characterization of hemodynamic events following intravascular infusion of recombinant adenovirus reveals possible solutions for mitigating cardiovascular responses |
| Q40528538 | Effect of adenovirus serotype 5 fiber and penton modifications on in vivo tropism in rats |
| Q33387265 | Induction of shock after intravenous injection of adenovirus vectors: a critical role for platelet-activating factor |
| Q64245487 | Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses |
| Q47353872 | Severe pulmonary pathology after intravenous administration of vectors in cirrhotic rats |
| Q45862533 | Titer determination of Ad5 in blood: a cautionary note |
| Q45873058 | Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeys |
| Q45872936 | Unexpected pulmonary uptake of adenovirus vectors in animals with chronic liver disease |
| Q38734134 | cDNA microarray assays to evaluate immune responses following intracranial injection of baculoviral vectors in non-human primates |
Search more.